Eddy Supriyadi

1.1k total citations
21 papers, 344 citations indexed

About

Eddy Supriyadi is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Eddy Supriyadi has authored 21 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Public Health, Environmental and Occupational Health, 13 papers in Pediatrics, Perinatology and Child Health and 10 papers in Oncology. Recurrent topics in Eddy Supriyadi's work include Acute Lymphoblastic Leukemia research (13 papers), Childhood Cancer Survivors' Quality of Life (11 papers) and Neutropenia and Cancer Infections (7 papers). Eddy Supriyadi is often cited by papers focused on Acute Lymphoblastic Leukemia research (13 papers), Childhood Cancer Survivors' Quality of Life (11 papers) and Neutropenia and Cancer Infections (7 papers). Eddy Supriyadi collaborates with scholars based in Indonesia, Netherlands and Kenya. Eddy Supriyadi's co-authors include A. Veerman, Jacqueline Cloos, Sutaryo Sutaryo, Ignatius Purwanto, Gertjan J.L. Kaspers, Festus Njuguna, Saskia Mostert, Mei Neni Sitaresmi, Raul C. Ribeiro and Alan Davidson and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Lancet Oncology and Pediatric Blood & Cancer.

In The Last Decade

Eddy Supriyadi

19 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eddy Supriyadi Indonesia 8 152 142 90 58 37 21 344
Rocío Cárdenas‐Cardós Mexico 11 131 0.9× 135 1.0× 88 1.0× 76 1.3× 38 1.0× 41 344
Zarina Abdul Latiff Malaysia 11 107 0.7× 46 0.3× 69 0.8× 45 0.8× 76 2.1× 53 349
Saad Ghazal‐Aswad United Arab Emirates 13 151 1.0× 71 0.5× 88 1.0× 42 0.7× 17 0.5× 29 414
Cheyenne Williams United States 9 130 0.9× 69 0.5× 181 2.0× 57 1.0× 57 1.5× 34 481
Mary Coerver- Connolly Ireland 9 39 0.3× 103 0.7× 97 1.1× 88 1.5× 17 0.5× 17 420
Marta Zapata‐Tarrés Mexico 11 163 1.1× 165 1.2× 108 1.2× 42 0.7× 44 1.2× 64 358
E. Mayer United States 3 159 1.0× 48 0.3× 109 1.2× 24 0.4× 70 1.9× 5 498
Karina I. Halilova United States 11 56 0.4× 170 1.2× 184 2.0× 19 0.3× 21 0.6× 24 396
Fisun Vural Türkiye 13 91 0.6× 195 1.4× 58 0.6× 37 0.6× 6 0.2× 52 495
Catherine Bender United States 10 104 0.7× 102 0.7× 162 1.8× 48 0.8× 6 0.2× 16 462

Countries citing papers authored by Eddy Supriyadi

Since Specialization
Citations

This map shows the geographic impact of Eddy Supriyadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eddy Supriyadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eddy Supriyadi more than expected).

Fields of papers citing papers by Eddy Supriyadi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eddy Supriyadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eddy Supriyadi. The network helps show where Eddy Supriyadi may publish in the future.

Co-authorship network of co-authors of Eddy Supriyadi

This figure shows the co-authorship network connecting the top 25 collaborators of Eddy Supriyadi. A scholar is included among the top collaborators of Eddy Supriyadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eddy Supriyadi. Eddy Supriyadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Supriyadi, Eddy, et al.. (2023). A province-wide childhood malignancy profiles in Indonesia (2010-2019): Yogyakarta Pediatric Cancer Registry. SHILAP Revista de lepidopterología. 63(4). 226–37. 2 indexed citations
4.
Sutaryo, Sutaryo, Sri Mulatsih, Eddy Supriyadi, et al.. (2022). Childhood acute lymphoblastic leukemia: Four years evaluation of protocols 2013 and 2016 in a single center in Indonesia, a lower‐middle‐income country. Pediatric Blood & Cancer. 69(11). e29875–e29875. 7 indexed citations
5.
Supriyadi, Eddy, et al.. (2022). Development and Evaluation of Internet-based Health Technology in Pediatric Oncology: A Scoping Review. Asian Pacific Journal of Cancer Prevention. 23(4). 1125–1135. 8 indexed citations
6.
Rusmawatiningtyas, Desy, et al.. (2022). Lag time to diagnosis as a predictor of mortality in children with extraocular retinoblastoma: Experience from a developing country. Asia-Pacific Journal of Clinical Oncology. 18(6). 706–713. 2 indexed citations
7.
Sitaresmi, Mei Neni, Sri Mulatsih, Eddy Supriyadi, et al.. (2021). Impact of universal health coverage on childhood cancer outcomes in Indonesia. Pediatric Blood & Cancer. 68(9). e29186–e29186. 7 indexed citations
8.
Bashari, Muhammad Hasan, et al.. (2021). Monitoring Of High-Dose Methotrexate (Mtx)-Related Toxicity and Mtx Levels in Children with Acute Lymphoblastic Leukemia: A Pilot-Study in Indonesia. Asian Pacific Journal of Cancer Prevention. 22(7). 2025–2031. 4 indexed citations
9.
Triasih, Rina, et al.. (2021). #8: Survival Analysis in Childhood Acute Myeloblastic Leukemia: Do Infection and Lymphocyte-Mediated Immune Response Play a Role?. Journal of the Pediatric Infectious Diseases Society. 10(Supplement_1). S17–S18.
10.
Triasih, Rina, et al.. (2021). #23: Survival Analysis of Childhood Acute Myeloblastic Leukemia in a Limited Resource Center: Do Infection and Lymphocyte-Mediated Immune Response Play a Role?. Journal of the Pediatric Infectious Diseases Society. 10(Supplement_1). S18–S18.
11.
Veerman, A., Eddy Supriyadi, & Sutaryo Sutaryo. (2020). Developing leukemia protocols in cooperation between the Netherlands and Indonesia. SHILAP Revista de lepidopterología. 5(1). 7–10. 3 indexed citations
12.
Bansal, Deepak, Alan Davidson, Eddy Supriyadi, et al.. (2019). SIOP PODC adapted risk stratification and treatment guidelines: Recommendations for acute myeloid leukemia in resource‐limited settings. Pediatric Blood & Cancer. 70(11). e28087–e28087. 21 indexed citations
13.
Supriyadi, Eddy, et al.. (2018). Faktor Prognostik dan Kesintasan Pasien Leukemia Limfoblastik Akut Anak di RSUP Dr. Sardjito, Yogyakarta, 2010–2015. SHILAP Revista de lepidopterología. 11(4). 145–145. 7 indexed citations
14.
Supriyadi, Eddy, et al.. (2017). Dexamethasone versus Prednisone in Childhood Acute Lymphoblastic Leukemia Treatment: Results of the Indonesian Randomized Trial. Journal of Cancer Therapy. 8(8). 735–750. 2 indexed citations
15.
Sitaresmi, Mei Neni, Eddy Supriyadi, Festus Njuguna, et al.. (2016). Delays in diagnosis and treatment of childhood cancer in Indonesia. Pediatric Blood & Cancer. 63(12). 2189–2196. 35 indexed citations
16.
Mostert, Saskia, et al.. (2015). Corruption in health-care systems and its effect on cancer care in Africa. The Lancet Oncology. 16(8). e394–e404. 52 indexed citations
17.
18.
Supriyadi, Eddy, A. Veerman, Yetty Movieta Nency, et al.. (2011). Immunophenotypic patterns of childhood acute leukemias in Indonesia.. PubMed. 12(12). 3381–7. 7 indexed citations
19.
Supriyadi, Eddy, et al.. (2011). Incidence of childhood leukemia in Yogyakarta, Indonesia, 1998–2009. Pediatric Blood & Cancer. 57(4). 588–593. 23 indexed citations
20.
Giovannetti, Elisa, Eddy Supriyadi, Desiree De Lange, et al.. (2007). Methylenetetrahydrofolate reductase (MTHFR) C677T and thymidylate synthase promoter (TSER) polymorphisms in Indonesian children with and without leukemia. Leukemia Research. 32(1). 19–24. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rocío Cárdenas‐Cardós Breakdown of academic impact, for papers by Zarina Abdul Latiff Breakdown of academic impact, for papers by Saad Ghazal‐Aswad Breakdown of academic impact, for papers by Cheyenne Williams Breakdown of academic impact, for papers by Mary Coerver- Connolly Breakdown of academic impact, for papers by Marta Zapata‐Tarrés Breakdown of academic impact, for papers by E. Mayer Breakdown of academic impact, for papers by Karina I. Halilova Breakdown of academic impact, for papers by Fisun Vural Breakdown of academic impact, for papers by Catherine Bender
Rankless by CCL
2026